Protocol No
PULM-ANSUN-BIOPHARMA-FQ
Staff Member
Mark Barash
Phase
III
Summary
This project is being done to see if DAS181 can help doctors care for immunocompromised patients with lower respiratory tract infections caused by PIV.
Objective
Lower Respiratory Tract PIV Infection in Immunocompromised Subjects
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov